XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.21.2

Employee Benefit Plans | 9 Months Ended
--- | ---
Oct. 03, 2021
Employee Benefits And Share Based Compensation [Abstract] |
Employee Benefit Plans | Note 10. Employee Benefit Plans The Company grants options, RSUs and performance shares under the 2016 Incentive Plan (the "2016 Plan"), under which awards may be granted to all employees. Vesting periods under this plan are generally four years for options and RSUs and three years for performance shares. As of October 3, 2021, approximately 1.8 million shares were reserved for future grants under the 2016 Plan. Additionally, the Company sponsors an Employee Stock Purchase Plan (the “ESPP”), pursuant to which eligible employees may contribute up to 10% of compensation, subject to certain income limits, to purchase shares of the Company's common stock. The terms of the plan include a look-back feature that enables employees to purchase stock semi-annually at a price equal to 85% of the lesser of the fair market value at the beginning of the offering period or the purchase date. The duration of each offering period is generally six-months. As of October 3, 2021, approximately 0.2 million shares were available for issuance under the ESPP. Option Activity Stock option activity during the nine months ended October 3, 2021 was as follows:
|  | Number of Shares |  |  | Weighted Average Exercise Price Per Share |
|  | (In thousands) |  |  | (In dollars) |
Outstanding as of December 31, 2020 |  |  | 1,333 |  |  | $ | 27.86 |
Exercised |  |  | (393 | ) |  | $ | 22.88 |
Outstanding as of October 3, 2021 |  |  | 940 |  |  | $ | 29.93 |
RSU Activity RSU activity during the nine months ended October 3, 2021 was as follows:
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value Per Share |
|  | (In thousands) |  |  | (In dollars) |
Outstanding as of December 31, 2020 |  |  | 1,584 |  |  | $ | 30.66 |
Granted |  |  | 731 |  |  | $ | 38.77 |
Vested |  |  | (618 | ) |  | $ | 31.53 |
Cancelled |  |  | (114 | ) |  | $ | 33.25 |
Outstanding as of October 3, 2021 |  |  | 1,583 |  |  | $ | 33.88 |
Performance Shares Activity In July 2020 and July 2021, the Company's executive officers were granted performance shares with vesting occurring at the end of a three-year period if performance conditions are met. The number of performance shares earned and eligible to vest are determined based on achievement of the pre-determined performance conditions and the recipients’ continued service with the Company. The number of performance shares to vest could range from 0% to 150% of the target shares granted. At the end of each reporting period, the Company evaluates the probability of achieving the performance conditions and records the related stock-based compensation expense based on performance to date over the service period. Performance shares activity during the nine months ended October 3, 2021 was as follows:
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value Per Share |
|  | (In thousands) |  |  | (In dollars) |
Outstanding as of December 31, 2020 |  |  | 141 |  |  | $ | 28.22 |
Granted |  |  | 152 |  |  | $ | 37.58 |
Vested |  |  | — |  |  | $ | — |
Cancelled |  |  | — |  |  | $ | — |
Outstanding as of October 3, 2021 |  |  | 293 |  |  | $ | 33.07 |
Valuation and Expense Information The Company measures stock-based compensation at the grant date based on the estimated fair value of the award. Estimated compensation cost relating to RSUs and performance shares is based on the closing fair market value of the Company's common stock on the date of grant. The fair value of options granted and the purchase rights granted under the ESPP is estimated on the date of grant using a Black-Scholes-Merton option valuation model that uses the assumptions noted in the following table. The estimated expected term of options granted is derived from historical data on employee exercise and post-vesting employment termination behavior. The risk-free interest rate of options granted and the purchase rights granted under the ESPP is based on the implied yield currently available on U.S. Treasury securities with a remaining term commensurate with the estimated expected term. Expected volatility of options granted under the 2016 Plan and the purchase rights granted under the ESPP is based on historical volatility over the most recent period commensurate with the estimated expected term. No options were granted during the three or nine months ended October 3, 2021 and September 27, 2020. The following table sets forth the weighted average assumptions used to estimate the fair value of purchase rights granted under the ESPP during the three and nine months ended October 3, 2021 and September 27, 2020:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | October 3, 2021 |  |  | September 27, 2020 |  |  | October 3, 2021 |  |  | September 27, 2020 |
Expected life (in years) |  |  | 0.5 |  |  |  | 0.5 |  |  |  | 0.5 |  |  |  | 0.5 |
Risk-free interest rate |  |  | 0.05 | % |  |  | 0.12 | % |  |  | 0.05 | % |  |  | 0.72 | %
Expected volatility |  |  | 34.7 | % |  |  | 66.4 | % |  |  | 40.8 | % |  |  | 54.8 | %
Dividend yield |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
The following table sets forth the stock-based compensation expense resulting from stock options, RSUs, performance shares and the ESPP included in the Company's unaudited condensed consolidated statements of operations:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | October 3, 2021 |  |  | September 27, 2020 |  |  | October 3, 2021 |  |  | September 27, 2020 |
|  | (In thousands) |
Cost of revenue |  | $ | 430 |  |  | $ | 923 |  |  | $ | 1,626 |  |  | $ | 3,129 |
Research and development |  |  | 1,414 |  |  |  | 1,138 |  |  |  | 3,832 |  |  |  | 3,879 |
Sales and marketing |  |  | 2,008 |  |  |  | 1,927 |  |  |  | 5,741 |  |  |  | 5,596 |
General and administrative |  |  | 2,358 |  |  |  | 3,230 |  |  |  | 8,873 |  |  |  | 10,122 |
Total |  | $ | 6,210 |  |  | $ | 7,218 |  |  | $ | 20,072 |  |  | $ | 22,726 |
As of October 3, 2021, $1.2 million of unrecognized compensation cost related to stock options was expected to be recognized over a weighted-average period of 1.5 years and $42.4 million of unrecognized compensation cost related to unvested RSUs and performance shares was expected to be recognized over a weighted-average period of 2.6 years.

X
- Definition The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 712 -URI http://asc.fasb.org/topic&trid=2197446 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -URI http://asc.fasb.org/topic&trid=2127225 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -URI http://asc.fasb.org/topic&trid=2235017 + Details
Name: | us-gaap_CompensationAndEmployeeBenefitPlansTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EmployeeBenefitsAndShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration